Neogen® To Participate in 2023 Wells Fargo Healthcare Conference
Werte in diesem Artikel
LANSING, Mich., Aug. 31, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2023 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 7.
David Naemura, Neogen's Chief Financial Officer, will present at 10:15 AM Eastern Time.
To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.
About Neogen
Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." The Company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.
Media Contact
Bill Waelke, Vice President, IR & Treasury
IR@Neogen.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-to-participate-in-2023-wells-fargo-healthcare-conference-301914468.html
SOURCE Neogen Corporation
Ausgewählte Hebelprodukte auf Neogen
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Neogen
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Neogen Aktie News
Neogen Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogen nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.11 | Neogen neutral | J.J.B. Hilliard, W.L. Lyons, Inc. | |
| 22.07.09 | Neogen buy | ROTH Capital Partners, LLC | |
| 20.03.09 | Neogen buy | ROTH Capital Partners, LLC | |
| 07.01.09 | Neogen Kursziel gesenkt | ROTH Capital Partners, LLC | |
| 26.09.08 | Neogen neues Kursziel | ROTH Capital Partners, LLC |

